Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
Experimental Parasitology
|
January 10, 2017
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review
Wesley C Van Voorhis, J Stone Doggett, Marilyn Parsons, et al.
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
ACS Medicinal Chemistry Letters
|
December 1, 2010
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii
Ryan C Murphy, Kayode K Ojo, Eric T Larson, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
April 9, 2019
Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro
Aruna Shrestha, Kayode K Ojo, Florian Koston, et al.
The Journal of Infectious Diseases
|
May 26, 2017
Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection
Samuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
International Journal of Antimicrobial Agents
|
July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice
Nicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
Cancer
|
March 27, 2018
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy
I Brian Greenwell, Ashley D Staton, Michael J Lee, et al.
Journal of Medicinal Chemistry
|
February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity
Steven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
The Journal of Infectious Diseases
|
December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
Experimental Parasitology
|
January 10, 2017
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review
Wesley C Van Voorhis, J Stone Doggett, Marilyn Parsons, et al.
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
ACS Medicinal Chemistry Letters
|
December 1, 2010
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii
Ryan C Murphy, Kayode K Ojo, Eric T Larson, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
April 9, 2019
Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro
Aruna Shrestha, Kayode K Ojo, Florian Koston, et al.
The Journal of Infectious Diseases
|
May 26, 2017
Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection
Samuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
International Journal of Antimicrobial Agents
|
July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice
Nicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
Cancer
|
March 27, 2018
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy
I Brian Greenwell, Ashley D Staton, Michael J Lee, et al.
Journal of Medicinal Chemistry
|
February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity
Steven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
The Journal of Infectious Diseases
|
December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
Page
of 23